Pasar al contenido principal

MECANISMOS MOLECULARES IMPLICADOS EN DAÑO CEREBRAL Y NEURODEGENERACION CAUSADOS POR DEFICIENCIAS EN KIDINS220 O POR ELIMINACION SELECTIVA DE PKD1 EN NEURONAS Y ASTROCITOS.

SAF2017-88885-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2017
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Differential regulation of Kidins220 isoforms in Huntington's disease

  • Sebastián-Serrano, Álvaro
  • Simón-García, Ana
  • Belmonte-Alfaro, Alicia
  • Pose-Utrilla, Julia
  • Santos-Galindo, María
  • Puerto, Ana del
  • García-Guerra, Lucía
  • Hernández, Ivó H.
  • Schiavo, Giampietro
  • Campanero, Miguel R.
  • Lucas, José Javier
  • Iglesias, Teresa
Huntington's disease (HD) is an inherited progressive neurodegenerative disease characterized by brain atrophy particularly in the striatum that produces motor impairment, and cognitive and psychiatric disturbances. Multiple pathogenic mechanisms have been proposed including dysfunctions in neurotrophic support and calpain-overactivation, among others. Kinase D-interacting substrate of 220 kDa (Kidins220), also known as ankyrin repeat-rich membrane spanning (ARMS), is an essential mediator of neurotrophin signaling. In adult brain, Kidins220 presents two main isoforms that differ in their carboxy-terminal length and critical protein-protein interaction domains. These variants are generated through alternative terminal exon splicing of the conventional exon 32 (Kidins220-C32) and the recently identified exon 33 (Kidins220-C33). The lack of domains encoded by exon 32 involved in key neuronal functions, including those controlling neurotrophin pathways, pointed to Kidins220-C33 as a form detrimental for neurons. However, the functional role of Kidins220-C33 in neurodegeneration or other pathologies, including HD, has not been explored. In the present work, we discover an unexpected selective downregulation of Kidins220-C33, in the striatum of HD patients, as well as in the R6/1 HD mouse model starting at early symptomatic stages. These changes are C33-specific as Kidins220-C32 variant remains unchanged. We also find the early decrease in Kidins220-C33 levels takes place in neurons, suggesting an unanticipated neuroprotective role for this isoform. Finally, using ex vivo assays and primary neurons, we demonstrate that Kidins220-C33 is downregulated by mechanisms that depend on the activation of the protease calpain. Altogether, these results strongly suggest that calpain-mediated Kidins220-C33 proteolysis modulates onset and/or progression of HD., This work was supported by the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) grants to T.I. (SAF2017‐88885‐R), J.J.L. (SAF2015‐65371‐R) and M.R.C. (SAF2017‐88881‐R); by B2017/BMD‐3700 NEUROMETAB‐CM (Comunidad de Madrid, Madrid, Spain) to T.I. and institutional grants to CBMSO from Fundación Ramón Areces and Fundación Banco de Santander to J.J.L. T.I. and J.J.L. are also funded by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED) and CIBERNED cooperative project 2015‐2/06 (Instituto de Salud Carlos III, Spain). GS work was supported by the Wellcome Trust Senior Investigator Award (107116/Z/15/Z), the European Union's Horizon 2020 Research and Innovation programme under grant agreement 739572 and a UK Dementia Research Institute Foundation award. A.S.‐S. was funded by a contract from CIBERNED‐2015‐2/06.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Excitotoxic targeting of Kidins220 to the Golgi apparatus precedes calpain cleavage of Rap1-activation complexes

  • López-Menéndez, Celia
  • Simón-García, Ana
  • Gamir-Morralla, Andrea
  • Pose-Utrilla, Julia
  • Luján, Rafael
  • Mochizuki, Naoki
  • Díaz-Guerra, Margarita
  • Iglesias, Teresa
© The Author(s) 2019., Excitotoxic neuronal death induced by high concentrations of glutamate is a pathological event common to multiple acute or chronic neurodegenerative diseases. Excitotoxicity is mediated through overactivation of the N-Methyl-D-aspartate type of ionotropic glutamate receptors (NMDARs). Physiological stimulation of NMDARs triggers their endocytosis from the neuronal surface, inducing synaptic activity and survival. However almost nothing is known about the internalization of overactivated NMDARs and their interacting proteins, and how this endocytic process is connected with neuronal death has been poorly explored. Kinase D-interacting substrate of 220 kDa (Kidins220), also known as ankyrin repeat-rich membrane spanning (ARMS), is a component of NMDAR complexes essential for neuronal viability by the control of ERK activation. Here we have investigated Kidins220 endocytosis induced by NMDAR overstimulation and the participation of this internalization step in the molecular mechanisms of excitotoxicity. We show that excitotoxicity induces Kidins220 and GluN1 traffic to the Golgi apparatus (GA) before Kidins220 is degraded by the protease calpain. We also find that excitotoxicity triggers an early activation of Rap1-GTPase followed by its inactivation. Kidins220 excitotoxic endocytosis and subsequent calpain-mediated downregulation governs this late inactivation of Rap1 that is associated to decreases in ERK activity preceding neuronal death. Furthermore, we identify the molecular mechanisms involved in the excitotoxic shutoff of Kidins220/Rap1/ERK prosurvival cascade that depends on calpain processing of Rap1-activation complexes. Our data fit in a model where Kidins220 targeting to the GA during early excitotoxicity would facilitate Rap1 activation and subsequent stimulation of ERK. At later times, activation of Golgi-associated calpain, would promote the degradation of GA-targeted Kidins220 and two additional components of the specific Rap1 activation complex, PDZ-GEF1, and S-SCAM. In this way, late excitotoxicity would turn off Rap1/ERK cascade and compromise neuronal survival., This work was funded by grants SAF2014-52737-P and SAF2017-88885-R to T.I., BFU2016-75973-R to M.D.-G and BFU2015-63769-R to R.L. (Spanish Ministry ofScience, Innovation and Universities—MICIU, Spain). It was also supported by grant SBPLY/17/180501/000229 from Junta de Comunidades de Castilla-La Mancha to R.L. Additional funding to T.I. was received by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) as well as by grant S2017/BMD3700 (NEUROMETAB-CM) from Comunidad de Madrid co-financed with the Structural Funds of the European Union (FEDER). A.G.-M. was funded by contracts from CIBERNED. Contracts to A.S.-G and J.P.U were funded by grants S2017/BMD-3700 (NEUROMETAB-CM) and SAF2017-88885-R, respectively. The cost of this publication has been paid in part by FEDER funds.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effects of thioflavin T and GSK-3 inhibition on lifespan and motility in a Caenorhabditis elegans model of tauopathy

  • Gamir-Morralla, Andrea
  • Sacristán, Sandra
  • Medina, Miguel
  • Iglesias, Teresa
The nematode Caenorhabditis elegans (C. elegans) is a powerful model organism to study lifespan and aging, protein aggregation, and neurodegeneration, as well as to carry out drug screenings. The C. elegans strain aex-3/T337 expresses human pathogenic V337M mutant tau under a pan-neuronal promoter and presents uncoordinated locomotion, accumulation of phosphorylated insoluble tau, and shortened lifespan. Herein we have used this strain to assay two compounds that could affect tau aggregation and/or phosphorylation, and looked for phenotypic changes in their lifespan and motility. The first compound is Thioflavin T (ThT), a member of the tetracycline family with protein antiaggregant properties, yet to be tested in a tauopathy model. The second is a novel small molecule, NP103, a highly selective inhibitor of glycogen synthase kinase-3 (GSK-3), the main kinase contributing to pathogenic tau hyperphosphorylation. Importantly, we find that ThT extends lifespan of aex-3/T337 worms as it does with control N2 animals, showing both strains similar locomotion features under this treatment. By contrast, NP103 improves the paralysis phenotype of aex-3/T337 mutants but not their lifespan. Our results show that both treatments present beneficial effects for this model of tauopathy and encourage pursuing further investigations on their therapeutic potential for AD and other tauopathies., This work was supported by grants SAF2014-52737-P and SAF2017-88885-R to T.I., SAF2016-78603-R to M.M. from Ministerio de Ciencia, Innovación y Universidades (Spain). It was also funded by B2017/BMD-3700 (NEUROMETAB-CM) from Comunidad de Madrid to T.I., and Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) to T.I. and M.M. A.G.M was funded by a contract from CIBERNED. The cost of this publication has been paid in part by FEDER (European Funds for Regional Development) funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CDCA7 finely tunes cytoskeleton dynamics to promote lymphoma migration and invasion

  • Martín-Cortázar, Carla
  • Chiodo, Yuri
  • Jiménez Pérez, Raúl
  • Bernabé, Manuel
  • Cayuela, María Luisa
  • Iglesias, Teresa
  • Campanero, Miguel R.
Metastases, the major cause of death from cancer, require cells’ acquisition of the ability to migrate and involve multiple steps, including local tumor cell invasion and basement membrane penetration. Certain lymphoid tumors are highly metastatic, but the mechanisms of invasion by lymphoma cells are poorly understood. We recently showed that CDCA7, a protein induced by MYC, is overexpressed in lymphoid tumors and that its knockdown decreases lymphoid tumor growth without inhibiting the proliferation of normal cells. Here we show that CDCA7 is critical for invasion and migration of lymphoma cells. Indeed, CDCA7 knockdown in lymphoma cells limited tumor cell invasion in matrigel-coated transwell plates and tumor invasion of neighboring tissues in a mouse xenograft model and in a zebrafish model of cell invasion. CDCA7 silencing markedly inhibited lymphoma cell migration on fibronectin without modifying cell adhesion to this protein. Instead, CDCA7 knockdown markedly disrupted the precise dynamic reorganization of actomyosin and tubulin cytoskeletons required for efficient migration. In particular, CDCA7 silencing impaired tubulin and actomyosin cytoskeleton polarization, increased filamentous actin formation, and induced myosin activation. Of note, inhibitors of actin polymerization, myosin II, or ROCK reestablished the migration capacity of CDCA7-silenced lymphoma cells. Given the critical role of CDCA7 in lymphoma-genesis and invasion, therapies aimed at inhibiting its expression or activity might provide significant control of lymphoma growth, invasion, and metastatic dissemination., The authors thank D. Trono for plasmids; the Spanish Ministerio de Economía y Competitividad for grants SAF2017-88881-R and SAF2017-88885-R (MINECO/AEI/FEDER, UE) to MRC and TIV, respectively; the Comunidad de Madrid for European Social Fund (ESF) cofinanced AORTASANA- CM; B2017/BMD- 3676 programme to MRC; and Instituto de Salud Carlos III (CIBERNED) for funding to TIV. The cost of this publication was paid in part with FEDER funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation

  • Puerto, Ana del
  • Pose-Utrilla, Julia
  • Simón-García, Ana
  • López-Menéndez, Celia
  • Jiménez, Antonio J.
  • Porlan, Eva
  • Pajuelo, Luis S. M.
  • Cano-García, Guillermo
  • Martí-Prado, Beatriz
  • Sebastián-Serrano, Álvaro
  • Sánchez-Carralero, Marina P.
  • Cesca, Fabrizia
  • Schiavo, Giampietro
  • Ferrer, Isidro
  • Fariñas, Isabel
  • Campanero, Miguel R.
  • Iglesias, Teresa
Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives., This work was supported by Spanish grants SAF2017-88885-R to TI and SAF2017-88881-R to MRC from the Spanish Ministerio de Economía y Competitividad/Agencia Estatal de Investigación/European Union Funds for Regional Development (MINECO/AEI/ FEDER, EU); by Comunidad de Madrid through the European Social Fund (ESF)-financed programme NEUROMETAB-CM (B2017/BMD-3700) to TI and AORTASANA-CM (B2017/BMD-3676) to MRC; by ‘La Caixa’ Banking Foundation project HR18-00068 to MRC; by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain) CB06/05/1122 to TI and collaborative grant CIBERNED PI2018/06 to TI and IFa; by grant PID2019-104763RB-100 and Ramón y Cajal programme contract (RYC-2014-15991), both from MINECO/AEI/FEDER (EU) to EP; by Wellcome Trust Senior Investigator Award (107116/Z/15/Z), the European Union’s Horizon 2020 Research and Innovation programme under grant agreement 739572 and a UK Dementia Research Institute Foundation award, all to GS; by grant PI19/00778 to AJJ from the Spanish Instituto de Salud Carlos III, co-funded by FEDER (EU); by Spanish grants from FEDER/Ministerio de Ciencia e Innovación (MICI)–AEI (SAF2017-86690-R), Network of Excellence iDIFFER (RED2018-102723-T), Instituto de Salud Carlos III (CIBERNED CB06/05/0086 and RETIC Tercel RD16/0011/0017) and Generalitat Valenciana (Prometeo 2017/030) to IFa. ADP was funded by a Juan de la Cierva Formación programme contract (FJCI-2014-19673; MINECO) and CIBERNED; JP-U was contracted by SAF2017-88885-R grant; AS-S was contracted by grants CIBERNED-PI2015-2/06 and PI2018/06, and SAF2017-88885-R; AS-G was funded by a contract from B2017/BMD-3700 grant and LSMP by a PhD training contract (PRE2018-086989) associated to grant SAF2017-88885-R.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease

  • Picó, Sara
  • Parras, Alberto
  • Santos-Galindo, María
  • Pose-Utrilla, Julia
  • Castro, Margarita
  • Fraga, Enrique
  • Hernández, Ivó H.
  • Elorza, Ainara
  • Anta, Héctor
  • Wang, Nan
  • Martí-Sánchez, Laura
  • Belloc, Eulàlia
  • García-Esparcia, Paula
  • Garrido, Juan J.
  • Ferrer, Isidro
  • Macías García, Daniel
  • Mir, Pablo
  • Artuch, Rafael
  • Pérez, Belén
  • Hernández, Félix
  • Navarro, Pilar
  • López-Sendón, José Luis
  • Iglesias, Teresa
  • Yang, X. William
  • Méndez, Raúl
  • Lucas, José Javier
Huntington’s disease (HD) is a hereditary neurodegenerative disorder of the basal ganglia for which disease-modifying treatments are not yet available. Although gene-silencing therapies are currently being tested, further molecular mechanisms must be explored to identify druggable targets for HD. Cytoplasmic polyadenylation element binding proteins 1 to 4 (CPEB1 to CPEB4) are RNA binding proteins that repress or activate translation of CPE-containing transcripts by shortening or elongating their poly(A) tail. Here, we found increased CPEB1 and decreased CPEB4 protein in the striatum of patients and mouse models with HD. This correlated with a reprogramming of polyadenylation in 17.3% of the transcriptome, markedly affecting neurodegeneration-associated genes including PSEN1, MAPT, SNCA, LRRK2, PINK1, DJ1, SOD1, TARDBP, FUS, and HTT and suggesting a new molecular mechanism in neurodegenerative disease etiology. We found decreased protein content of top deadenylated transcripts, including striatal atrophy–linked genes not previously related to HD, such as KTN1 and the easily druggable SLC19A3 (the ThTr2 thiamine transporter). Mutations in SLC19A3 cause biotin-thiamine–responsive basal ganglia disease (BTBGD), a striatal disorder that can be treated with a combination of biotin and thiamine. Similar to patients with BTBGD, patients with HD demonstrated decreased thiamine in the cerebrospinal fluid. Furthermore, patients and mice with HD showed decreased striatal concentrations of thiamine pyrophosphate (TPP), the metabolically active form of thiamine. High-dose biotin and thiamine treatment prevented TPP deficiency in HD mice and attenuated the radiological, neuropathological, and motor HD-like phenotypes, revealing an easily implementable therapy that might benefit patients with HD., This work was supported by CIBERNED-ISCIII collaborative grants 2013/09-2 to J.J.L. and 2015-2/06 and 2018/06-5 to J.J.L. and T.I., grants SAF2015-65371-R (MINECO/AEI/FEDER, UE), and grants from the Spanish Ministry of Science, Innovation and Universities (MINECO/MICINN): RTI2018-096322-B-I00 (MCIU/AEI/FEDER, UE) to J.J.L., SAF2017-88885-R (MINECO/AEI/FEDER, UE) to T.I., BFU2014-54122-P (MINECO/AEI/FEDER, UE) to R.M., and ISCIII-FEDER (PI17/00199; PI20/00625) to P.N. This work was also supported by the European Union FEDER funds, Fundación Botín–Banco Santander through its Santander Universities Global Division and Fundación Ramón Areces. A.P. and S.P. were recipients of FPI fellowships from MICINN/MINECO. A.P. was also hired through CIBERNED. J.P.-U. was contracted by SAF2017-88885-R (MINECO/AEI/FEDER, UE). D.M.-G. was supported by the “Río Hortega” programme (CM18/00142) from ISCIII-FEDER. A.E. was a recipient of Juan de la Cierva contracts from MICINN/MINECO., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington¿s disease

  • Picó, Sara
  • Parras, Alberto
  • Santos-Galindo, María
  • Pose-Utrilla, Julia
  • Castro, Margarita
  • Fraga, Enrique
  • Hernández Hernández, Ivo
  • Elorza, Ainara
  • Anta, Héctor
  • Wang, Nan
  • Martí-Sánchez, Laura
  • Belloc, Eulàlia
  • García-Esparcia, Paula
  • Garrido Jurado, Juan José
  • Ferrer, Isidro
  • Macías García, Daniel
  • Mir, Pablo
  • Artuch, Rafael
  • Pérez, Belén
  • Hernández, Félix
  • Navarro Medrano, Pilar
  • López-Sendón, José Luis
  • Iglesias, Teresa
  • Yang, Willian
  • Méndez, Raúl
  • Lucas, José Javier
Huntington’s disease (HD) is a hereditary neurodegenerative disorder of the basal ganglia for which disease-modifying treatments are not yet available. Although gene-silencing therapies are currently being tested, further molecular mechanisms must be explored to identify druggable targets for HD. Cytoplasmic polyadenylation element binding proteins 1 to 4 (CPEB1 to CPEB4) are RNA binding proteins that repress or activate translation of CPE-containing transcripts by shortening or elongating their poly(A) tail. Here, we found increased CPEB1 and decreased CPEB4 protein in the striatum of patients and mouse models with HD. This correlated with a reprogramming of polyadenylation in 17.3% of the transcriptome, markedly affecting neurodegeneration-associated genes including PSEN1, MAPT, SNCA, LRRK2, PINK1, DJ1, SOD1, TARDBP, FUS, and HTT and suggesting a new molecular mechanism in neurodegenerative disease etiology. We found decreased protein content of top deadenylated transcripts, including striatal atrophy–linked genes not previously related to HD, such as KTN1 and the easily druggable SLC19A3 (the ThTr2 thiamine transporter). Mutations in SLC19A3 cause biotin-thiamine–responsive basal ganglia disease (BTBGD), a striatal disorder that can be treated with a combination of biotin and thiamine. Similar to patients with BTBGD, patients with HD demonstrated decreased thiamine in the cerebrospinal fluid. Furthermore, patients and mice with HD showed decreased striatal concentrations of thiamine pyrophosphate (TPP), the metabolically active form of thiamine. High-dose biotin and thiamine treatment prevented TPP deficiency in HD mice and attenuated the radiological, neuropathological, and motor HD-like phenotypes, revealing an easily implementable therapy that might benefit patients with HD., This work was supported by CiberNed-ISCIII collaborative grants 2013/09-2 to J.J.L, 2015-2/06 and 2018/06-5 to J.J.L and T.I., and by grants SAF2015-65371-R (MINECO/AEI/FEDER, UE) and by grants from Spanish Ministry of Science, Innovation and Universities (MINECO/MICINN): RTI2018-096322-B-I00 (MCIU/AEI/FEDER, UE) to J.J.L., SAF2017- 88885-R (MINECO/AEI/FEDER, UE) to T.I., BFU2014-54122-P (MINECO/AEI/FEDER, UE) to R.M., and ISCIII-FEDER (PI17/00199) to P.N., by the European Union FEDER funds, the Fundación Botín by the Banco Santander through its Santander Universities Global Division, by Fundación BBVA and by Fundación Ramón Areces. A.P. and S.P. were recipients of FPI fellowships from MICINN/MINECO, A.P. was also recipient of a contract from CIBERNED, J.P.U. was contracted by SAF2017-88885-R (MINECO/AEI/FEDER, UE), D.M-G. was supported by the “Río Hortega” programme [CM18/00142] from ISCIII-FEDER, A.E. was recipient of Juan de la Cierva contracts from MICINN/MINECO.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

Papel de la Proteína Quinasa D1 en la modulación del estrés oxidativo y el envejecimiento cerebral, la supervivencia neuronal y la función sináptica

  • Pose-Utrilla, Julia
La realización de esta Tesis Doctoral ha sido posible gracias al disfrute de un contrato Predoctoral de Personal Investigador en Formación financiado por los proyectos SAF2014-52737-P (2017-2018) y SAF2017-88885-R (2018-2020), vinculados al Consejo Superior de Investigaciones Científicas (CSIC), así como un contrato de Titulado Superior de Actividades Técnicas y Profesionales financiado por el Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) (2020-2021)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival

  • Fernández-Albarral, Jose A.
  • Simón-García, Ana
  • Salobrar-García, Elena
  • Salazar, Juan J.
  • López-Menéndez, Celia
  • Pajuelo, Luis S. M.
  • Matamoros, Jose A.
  • Hoz, Rosa de
  • López-Cuenca, Inés
  • Elvira-Hurtado, Lorena
  • Sanchez-Puebla, Lidia
  • Sánchez-Carralero, Marina P.
  • Sanz, Marina
  • Ramírez, José M.
  • Iglesias, Teresa
  • Ramírez, Ana I.
Hydrocephalus, characterized by ventriculomegaly due to cerebrospinal fluid accumulation in the cerebral ventricles, is a co-morbidity factor in several neurodevelopmental, psychiatric and neurodegenerative diseases. Aquaporin-4 (AQP4) is crucial for brain water homeostasis, with Aqp4 knockout mice showing sporadic ventriculomegaly and increased brain water content. Kinase D interacting substrate of 220 kDa (Kidins220), a transmembrane protein involved in neuronal survival, synaptic activity and neurogenesis, controls AQP4 levels in ependymocytes and brain astrocytes. Indeed, Kidins220 deficiency in mice leads to hydrocephalus by downregulating VPS35, a key component of the retromer complex, and targeting AQP4 to lysosomal degradation. Importantly, the ependymal barrier of idiopathic normal pressure hydrocephalus patients shows a similar downregulation of KIDINS220 and AQP4. In addition, pathogenic variants in the KIDINS220 gene are linked to SINO syndrome, a rare disorder characterized by spastic paraplegia, intellectual disability, nystagmus, and obesity associated with hydrocephalus and ventriculomegaly. Given the retina’s structural and functional similarities to the brain, we hypothesized that Kidins220 deficiency would affect retinal water regulation. However, the diminished expression of Kidins220 and VPS35 in the retina of Kidins220-deficient hydrocephalus mice, did not cause edema or downregulate AQP4 in Müller cells. Surprisingly, there was an increase in AQP4 levels within this glial cell population. Conversely, AQP4 expression in the optic nerve astrocytes was reduced, as observed in brain astrocytes, suggesting a distinctive adaptive response to hydrocephalus in Müller glia within the Kidins220-deficient retina. Furthermore, we observed phenotypic modifications in retinal glia in Kidins220-deficient hydrocephalus mice. However, we did not find any signs of neuronal damage in the retina. Future studies using OCT and OCTA in SINO syndrome patients with ventriculomegaly will be essential in elucidating the relationship between KIDINS220 pathogenic variants, retinal alterations, papilledema, and visual function., LS-P is currently supported by a Predoctoral Fellowship (CT82/20-CT83/20) from the Complutense University of Madrid. JAM is currently supported by a Predoctoral Fellowship (CT58/21-CT59/21) from the Complutense University of Madrid. TI was supported by grants PID2020-115218RB-I00, funded by MCIN/AEI/10.13039/50110001133, and PID2023-153284OB-I00, funded by MCIU/AEI/ 10.13039/501100011033 and by ERDF/EU, and CB06/05/1122 Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III (ISCIII), Spain, funded by MCIU and supported in part by “ERDF A way of making Europe” funds. AS-G and MPS-C were supported by contracts associated to PID2020-115218RB-I00 and PID2023-153284OB-100 grants. LSMP was supported by a PhD training contract (PRE2018- 086989) associated to grant SAF2017-88885-R, and by PID2020-115218RB-I00 and PID2023-153284OB-100 grants. MS was contracted by CIBERNED (ISCIII)., Peer reviewed